CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases

Posted on | Posted on John Murphy | Leave a Comment on CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases

Matteo Foschi1,2 Samir Abu-Rumeileh3 Federico Massa4 Christian Cordano4,5 Ahmed Abdelhak5* 11 July 2023 Frontiers in Medicine CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases The past decades have witnessed advances in the development of ultrasensitive assays to measure biofluid markers to improve the diagnosis and characterization of central nervous system (CNS) involvement in primary and non-primary neurological […]

COVID-19 Vaccines Revealed To Be ‘Neither Safe, Nor Effective’

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Vaccines Revealed To Be ‘Neither Safe, Nor Effective’

SEP 19, 2023 – 06:30 AM Authored by Naveen Athrappully via The Epoch Times  COVID-19 vaccines were authorized in Canada during 2020 and 2021 without being subjected to the country’s safety tests as required under established drug regulations, revealed an accountability watchdog. An investigation into COVID vaccines found that the jabs were “neither safe nor […]

Myocarditis & COVID-19 Vaccines: How The CDC Missed A Safety Signal And Hid A Warning

Posted on | Posted on John Murphy | Leave a Comment on Myocarditis & COVID-19 Vaccines: How The CDC Missed A Safety Signal And Hid A Warning

MONDAY, SEP 18, 2023 – 02:25 PM Authored by Zachary Stieber The Epoch Times, COVID-19 vaccines cause heart inflammation, U.S. authorities now acknowledge. But after being warned in early 2021 about a “large number” of cases among healthy, young people in Israel after COVID-19 vaccination, authorities did not immediately alert the public while also failing to […]

Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases

Posted on | Posted on John Murphy | Leave a Comment on Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases

Ali Bodaghi,a Nadia Fattahi,b,c and Ali Ramazanib,d,∗ Heliyon. 2023 Feb; 9(2): e13323. Published online 2023 Jan 30. doi: 10.1016/j.heliyon.2023.e13323 PMCID: PMC9884646 PMID: 36744065 The use of biomarkers as early warning systems in the evaluation of disease risk has increased markedly in the last decade. Biomarkers are indicators of typical biological processes, pathogenic processes, or pharmacological reactions to therapy. The application and identification of biomarkers […]

Doctors Are Now Struggling to Differentiate Between Covid, Allergies, and Common Cold – ‘We Only Knew It Was Covid Because We Tested’

Posted on | Posted on John Murphy | Leave a Comment on Doctors Are Now Struggling to Differentiate Between Covid, Allergies, and Common Cold – ‘We Only Knew It Was Covid Because We Tested’

By Jim Hᴏft Sep. 17, 2023  Medical professionals are finding it increasingly challenging to distinguish between Covid-19, allergies, and the common cold. Gone are the days when the loss of taste or smell and a dry cough were the telltale signs of Covid-19. According to Dr. Erick Eiting, vice chair of operations for emergency medicine at Mount […]

Lung Damage & Shortness of Breath After the COVID-19 Vaccine

Posted on | Posted on John Murphy | Leave a Comment on Lung Damage & Shortness of Breath After the COVID-19 Vaccine

September 18, 2023 The COVID Long-haul Foundation: Opinion Shortness of breath is a side effect of the COVID-19 vaccine that has been found in vaccinated individuals. It can be caused by a few different things, including: Myocarditis and Pericarditis After the COVID-19 Vaccine Myocarditis and pericarditis are two types of heart inflammation that can occur […]

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Posted on | Posted on John Murphy | Leave a Comment on Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Maxime Taquet, Zuzanna Skorniewska, Adam Hampshire, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Linzy Houchen-Wolloff, Neil J. Greening, Parisa Mansoori, Ewen M. Harrison, Annemarie B. Docherty, Nazir I. Lone, PHOSP-COVID Study Collaborative Group Nature Medicine (August 2023)  Abstract Post-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective and […]

Predictive Role of Biomarkers in COVID-19 Mortality

Posted on | Posted on John Murphy | Leave a Comment on Predictive Role of Biomarkers in COVID-19 Mortality

Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

Accelerated biological aging in COVID-19 patients

Posted on | Posted on John Murphy | Leave a Comment on Accelerated biological aging in COVID-19 patients

Authors: Xue Cao, Wenjuan Li, Ting Wang, Dongzhi Ran,Veronica Davalos, Laura Planas-Serra, Aurora Pujol, Manel Esteller, Xiaolin Wang & Huichuan Yu  Nature Communications volume 13, 19 April 2022 Article number: 2135 (2022)  Abstract Chronological age is a risk factor for SARS-CoV-2 infection and severe COVID-19. Previous findings indicate that epigenetic age could be altered in viral infection. However, the epigenetic aging in COVID-19 has not been well studied. In […]

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Posted on | Posted on John Murphy | Leave a Comment on Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Vincent Zhang, Molly Fisher,Wei Hou,Lili Zhang and Tim Q. Duong      Aug 2023 Hypertension. 2023;0 Abstract BACKGROUND: SARS-CoV-2 may trigger new-onset persistent hypertension. This study investigated the incidence and risk factors associated with new-onset persistent hypertension during COVID-19 hospitalization and at ≈6-month follow-up compared with influenza. METHODS: This retrospective observational study was conducted in a major […]